Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
41 hedge funds and large institutions have $5.69M invested in Tobira Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 11 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
0% more call options, than puts
Call options by funds: $3K | Put options by funds: $3K
13% less funds holding
Funds holding: 47 → 41 (-6)
19% less capital invested
Capital invested by funds: $7.05M → $5.69M (-$1.36M)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$834K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$56.6K |
| 3 |
Renaissance Technologies
New York
|
+$37.8K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.8K |
| 5 |
Morgan Stanley
New York
|
+$35.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$693K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$143K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$114K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$69K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$47K |
TBRA Hedge Fund Activity: Q4 2014 in Review
41 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q4 2014, worth a combined $5.69M — down 19% from $7.05M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of TBRA and 7 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 13 added.
The largest buyer was Panagora Asset Management, adding an estimated $834K. The largest seller was BVF Inc, cutting an estimated $693K.
- 41 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q4 2014, down from 47 in Q3 2014.
- Funds reported $5.69M of Tobira Therapeutics, Inc. Common Stock stock for Q4 2014, down 19% quarter-over-quarter.
- 7 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q4 2014 and 11 closed out, a net change of -4 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q4 2014 was Panagora Asset Management, an estimated $834K added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q4 2014 was BVF Inc, an estimated $693K sold.
Based on aggregated 13F filings for Q4 2014.